In pre-clinical studies, it has been found that radiotherapy in combination with CD47 blockade could stimulate a potent macrophage-mediated abscopal effect in non-small cell lung cancer, lymphoma, and colon cancer models, leading to tumor control at both the irradiated and non-irradiated site [47]. The gene discussed is CD47; the disease is lymphoma.